Close Menu
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

November 16, 2026

Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture

November 16, 2026

Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker

November 16, 2026
Facebook X (Twitter) Instagram
Trending
  • Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
  • Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture
  • Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker
  • Beer-drinking, cigarette-smoking 87-year-old viral Internet golfer 'Par 3 Lee' drains another ace
  • Customer's restaurant receipt sparks controversy after $6 charge appears for to-go box
  • Ukraine hits Putin's prized bridge in record drone blitz as Kremlin tells lawmakers to prepare for 'victory'
  • Kylie Beck put down her Dolphins pom-poms and picked up a Cardinals jersey for Carson's first NFL start
  • Trump brings two divided Cabinet heavyweights to China as controversy hangs over high-stakes talks
Facebook X (Twitter) Instagram
NEW YORK TIMES POST
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
NEW YORK TIMES POST
Home»Lifetsyle»Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people
Lifetsyle

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

nytimespostBy nytimespostNovember 16, 2026No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


NEWYou can now listen to Fox News articles!

Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.

The research, published in The Lancet Psychiatry, compared 20 antidepressants to determine how well they eased depression symptoms and helped prevent them from returning over time.

Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.

CERTAIN SLEEP HABITS COULD OFFER CLUES TO HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAY

They found that escitalopram, sold under the brand name Lexapro; duloxetine, sold as Cymbalta; and agomelatine performed better over the long term than fluoxetine, which researchers used as the main comparison drug.

Eli Lilly told Fox News Digital that it discontinued manufacturing Prozac in 2024. The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product.

Man holding blood pressure medications

A new study suggests three antidepressants may work better than fluoxetine at helping people recover from depression and stay well over time. (iStock)

The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.

Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.

CLICK HERE FOR MORE HEALTH STORIES

“Escitalopram is already widely used,” he said in the release. “Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well-known and is prescribed less frequently as a first-line treatment.”

Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. These medications are often recommended as a first option for treating depression, according to the release.

Man holding the medicine bottle in one hand and pill in other

Researchers compared antidepressant treatments to better understand which medications may help patients maintain improvements and avoid a return of depression symptoms. (iStock)

Among the SSRIs included in the study, escitalopram appeared to work best at helping patients stay well over time.

Eric Ruhé, a professor of difficult-to-treat depression at Radboud University Medical Center, said the findings could eventually influence how doctors choose antidepressants. Still, the researchers stressed that this does not mean everyone with depression should take escitalopram.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“As a prescriber, you consider the balance between a medication’s benefits and side effects,” Ruhé said in the release. “That balance differs from person to person.”

Dr. Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, California, who was not involved in the study, urged caution when interpreting the findings.

Woman taking pill

Escitalopram, duloxetine and agomelatine appeared to outperform fluoxetine in maintaining improvements in depression symptoms over the long term. (iStock)

She noted that agomelatine is not approved in the U.S.

“The best way to treat someone with depression is not always with antidepressants, and certainly not with antidepressants alone,” Lieberman told Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy.

There were some limitations to the study, the researchers acknowledged.

Woman getting in-person therapy

Researchers cautioned that the findings cannot predict which antidepressant will work best for a specific patient, emphasizing the need for individualized treatment decisions. (iStock)

Rather than enrolling a new group of patients and following them over time, the researchers combined results from 115 previous clinical trials to compare how the medications performed.

The findings also cannot predict which antidepressant will work best for a specific person. The researchers stressed that doctors and patients should consider both the potential benefits and side effects when choosing a medication.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

People with questions about their antidepressants should speak with their doctor before making any medication changes, according to the release.

Fox News Digital reached out to the researchers and additional drug manufacturers for comment.

Kelly McGreal is a member of the lifestyle team at Fox News Digital. She and the team cover travel, food and drink, health, relationships and more. She also produces the weekly American Culture Quiz and handles other special projects. 

antidepressant depression drugs health major medical research medications mental health outperformed people study Widely
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

Ukraine hits Putin's prized bridge in record drone blitz as Kremlin tells lawmakers to prepare for 'victory'

November 16, 2026

Trump brings two divided Cabinet heavyweights to China as controversy hangs over high-stakes talks

November 16, 2026

Underdog Promo Code FOXNEWS: Get $50 When You Trade $10 on Ravens vs Chargers

November 16, 2026
Leave A Reply Cancel Reply

The Latest News
  • Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people November 16, 2026
  • Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture November 16, 2026
  • Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker November 16, 2026
  • Beer-drinking, cigarette-smoking 87-year-old viral Internet golfer 'Par 3 Lee' drains another ace November 16, 2026
  • Customer's restaurant receipt sparks controversy after $6 charge appears for to-go box November 16, 2026
  • Ukraine hits Putin's prized bridge in record drone blitz as Kremlin tells lawmakers to prepare for 'victory' November 16, 2026
Top Posts

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

November 16, 2026

Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture

November 16, 2026

Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker

November 16, 2026

Beer-drinking, cigarette-smoking 87-year-old viral Internet golfer 'Par 3 Lee' drains another ace

November 16, 2026
Don't Miss
Lifetsyle

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

By nytimespostNovember 16, 2026

NEWYou can now listen to Fox News articles! Three antidepressants may work better than fluoxetine,…

Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture

November 16, 2026

Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker

November 16, 2026

Beer-drinking, cigarette-smoking 87-year-old viral Internet golfer 'Par 3 Lee' drains another ace

November 16, 2026
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo

Subscribe to Updates

Get the latest creative news from SmartMag about art & design.

NEW YORK TIMES POST

 

Categories
  • Business
  • Culture
  • Fashion
  • Food
  • Tech
  • Sports
  • Travel
  • Nature
Services
  • News
  • Entertainment
  • Sports
  • World
  • Health
  • Lifetsyle
  • contact
About Us

Email Us: info@nytimespost.com
Contact:

Facebook X (Twitter) Pinterest YouTube WhatsApp
Our Picks

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

November 16, 2026

Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture

November 16, 2026

Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker

November 16, 2026
Most Popular

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

November 16, 2026

Dan Dakich rips into Lane Kiffin after LSU's loss to Texas eliminates Tigers from CFB Playoff picture

November 16, 2026

Senate Dem challenging Sen Chuck Schumer for leadership post backs Hakeem Jeffries for House speaker

November 16, 2026
© 2026 NY TIMES POST by NEW TORK TIMES POST.

Type above and press Enter to search. Press Esc to cancel.